Therapeutic Neuromodulation Systems

Therapeutic Neuromodulation Systems (TNMS) develops percutaneous electrical nerve stimulation (PENS) devices for non-pharmaceutical pain management, post-operative recovery, and opioid withdrawal management. The company's core technology is a wearable neurostimulator placed behind the ear that targets the vagal nerve and peripheral nerve endings to trigger endogenous release of pain-relieving substances such as endorphins. This mechanism reduces pain sensitivity, inflammation, and muscle tightness without pharmaceutical intervention. TNMS offers three integrated product lines: the MD Device for chronic and acute pain management; the POSP Device designed to minimize opioid dependence and accelerate surgical recovery; and The Morph, a specialized solution for managing opioid withdrawal symptoms. The devices are indicated for use in hospital, surgical, and clinical pain management settings as well as opioid detoxification programs. The company serves healthcare providers and patients seeking alternatives to pharmaceutical pain management and opioid-based therapies. Regulatory status and specific certifications (510(k), FDA clearance, ISO 13485) are not explicitly stated on the available website content but are typical requirements for such neurostimulation devices.